- Parties: The applicant was Sandoz Canada Inc. The respondents were Merck Sharp & Dohme LLC, Merck Canada Inc., Pfizer, and Eisai R&D Management Co., Ltd.

- Subject Matter: This Federal Court matter involves an action for copyright infringement filed by Sandoz Canada Inc. against Merck Sharp & Dohme LLC, Merck Canada Inc., Pfizer, and Eisai R&D Management Co., Ltd., with the Plaintiff tendering a payment of $15,000.00 into Court pursuant to Section 60(3) of the Patent Act. The case is ongoing.

- Date: The hearing was set on February 02, 2026.

- Venue: This was a federal case before the Federal Court.

- Amount: No financial award was specified.